Thienopyrimidines useful as Aurora kinase inhibitors
US7601725B2 · kind B2 · utility
1Cited by
34References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2005 |
| Grant date | Oct 13, 2009 |
| Priority date | — |
| Expiry date | Jul 16, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds having the formula:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.